Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2021 17:33 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Participation in Upcoming May Conferences

AUSTIN, TX and DURHAM, NC, April 30, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
April 28, 2021 16:45 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit

AUSTIN, Texas and DURHAM, N.C., April 28, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...
April 12, 2021 07:00 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Highlights Preclinical Data for SL-9258 (TIGIT-Fc-LIGHT) in an Acquired Resistance Model and Expanded Preclinical Data from the GADLEN™ Platform at AACR 2021

AUSTIN, TX and DURHAM, NC, April 12, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
April 06, 2021 07:00 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Participation in Needham’s 20th Annual Healthcare Conference

AUSTIN, TX and DURHAM, NC, April 06, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
March 16, 2021 07:00 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Promotion of Andrew R. Neill to Chief Financial Officer

AUSTIN, TX and DURHAM, NC, March 16, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of...
March 15, 2021 16:45 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), expected in the second half of 2021 – – Dose-escalation data...
March 11, 2021 08:28 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present Two Posters at the 2021 American Association for Cancer Research (AACR) Annual Meeting

AUSTIN, TX and DURHAM, NC, March 11, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
February 23, 2021 18:40 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Participation in Upcoming March Investor Conferences

AUSTIN, TX and DURHAM, NC, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
February 12, 2021 09:41 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day

AUSTIN, TX & DURHAM, NC, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...
January 07, 2021 17:27 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference

AUSTIN, TX and DURHAM, NC, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...